BRISTOL-MYERS SQUIBB COMPANY
BRISTOL-MYERS SQUIBB COMPANY is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANYThe registrant lobbying for itself | 2026-Q2: $3,160,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- JOHN DEOUDES · 1 report
- KATHRYN NOVARIA · 1 report
- KIRBY MILLER · 1 report
- LANE PENRY · 1 report
- MICHAEL CALVO · 1 report
- NICOLE ANNE L'ESPERANCE · 1 report · earlier government job reported
- RODGER CURRIE · 1 report
- SOFIA FOX · 1 report
- STEVEN TILTON · 1 report
- THOMAS BRUNET · 1 report
Bills named, and how the House and the Senate voted
5 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
| H.R. 5509Safe Step Act | Introduced | No recorded vote in our record |
| H.R. 7391Community Health Center Drug Pricing Protection Act | Introduced | No recorded vote in our record |
| H.R. 7635CHARGE Act | Introduced | No recorded vote in our record |
Issues named: Copyright/Patent/Trademark (1), Health Issues (1), Medicare/Medicaid (1), Taxation/Internal Revenue Code (1), Trade (domestic/foreign) (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANYTrade (domestic/foreign), Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Andrea Salinas DDemocrat | ANDREA SALINAS FOR OREGONFrom BRISTOL-MYERS SQUIBB COMPANY POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov | |
| Andrea Salinas DDemocrat | ANDREA SALINAS FOR OREGONFrom BRISTOL-MYERS SQUIBB COMPANY POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov | |
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom BRISTOL-MYERS SQUIBB COMPANY POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov | |
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom BRISTOL-MYERS SQUIBB COMPANY POLITICAL ACTION COMMITTEE | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.